- Home
- CARM vs GIPR Comparison
CARM vs GIPR Comparison
Compare CARM & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- GIPR
- Stock Information
- Founded
- CARM 2016
- GIPR 2015
- Country
- CARM United States
- GIPR United States
- Employees
- CARM N/A
- GIPR N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- GIPR Real Estate Investment Trusts
- Sector
- CARM Health Care
- GIPR Real Estate
- Exchange
- CARM Nasdaq
- GIPR Nasdaq
- Market Cap
- CARM 7.7M
- GIPR 8.0M
- IPO Year
- CARM N/A
- GIPR 2021
- Fundamental
- Price
- CARM $0.19
- GIPR $1.58
- Analyst Decision
- CARM Hold
- GIPR Hold
- Analyst Count
- CARM 5
- GIPR 1
- Target Price
- CARM $0.90
- GIPR N/A
- AVG Volume (30 Days)
- CARM 956.5K
- GIPR 14.7K
- Earning Date
- CARM 05-13-2025
- GIPR 05-15-2025
- Dividend Yield
- CARM N/A
- GIPR 2.47%
- EPS Growth
- CARM N/A
- GIPR N/A
- EPS
- CARM N/A
- GIPR N/A
- Revenue
- CARM $19,964,000.00
- GIPR $9,711,058.00
- Revenue This Year
- CARM N/A
- GIPR N/A
- Revenue Next Year
- CARM N/A
- GIPR N/A
- P/E Ratio
- CARM N/A
- GIPR N/A
- Revenue Growth
- CARM 32.45
- GIPR 11.25
- 52 Week Low
- CARM $0.14
- GIPR $1.43
- 52 Week High
- CARM $1.90
- GIPR $4.60
- Technical
- Relative Strength Index (RSI)
- CARM 44.76
- GIPR 46.52
- Support Level
- CARM $0.14
- GIPR $1.56
- Resistance Level
- CARM $0.20
- GIPR $1.77
- Average True Range (ATR)
- CARM 0.02
- GIPR 0.11
- MACD
- CARM 0.00
- GIPR -0.00
- Stochastic Oscillator
- CARM 71.47
- GIPR 21.79
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.